TipRanks
Go Ultimate55% OFF

InDex Pharmaceuticals Holding AB (FLERIE) Financial Statements

2 Followers

InDex Pharmaceuticals Holding AB Financial Overview

InDex Pharmaceuticals Holding AB's market cap is currently kr1.18B. The company's EPS TTM is kr-12.02; its P/E ratio is -1.06; InDex Pharmaceuticals Holding AB has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenuekr 8.80Mkr 100.00Kkr 97.50Mkr 0.00kr 0.00
Gross Profitkr -12.70Mkr -41.60Mkr 93.35Mkr -1.07Mkr -1.25M
Operating Incomekr -782.10Mkr -110.80Mkr -107.37Mkr -151.11Mkr -115.63M
EBITDAkr -743.60Mkr -225.70Mkr -93.82Mkr -99.15Mkr -101.66M
Net Incomekr -756.90Mkr -228.00Mkr -95.27Mkr -100.33Mkr -103.04M
Balance Sheet
Cash & Short-Term Investmentskr 540.20Mkr 865.10Mkr 294.27Mkr 344.93Mkr 428.45M
Total Assetskr 3.40Bkr 4.22Bkr 299.39Mkr 351.34Mkr 445.20M
Total Debtkr 2.10Mkr 800.00Kkr 2.30Mkr 3.25Mkr 1.28M
Net Debtkr -536.50Mkr -864.30Mkr -291.97Mkr -341.68Mkr -427.17M
Total Liabilitieskr 20.30Mkr 25.30Mkr 60.50Mkr 17.38Mkr 11.16M
Stockholders' Equitykr 3.38Bkr 4.20Bkr 238.88Mkr 333.96Mkr 434.04M
Cash Flow
Free Cash Flowkr -28.10Mkr -17.00Mkr -37.98Mkr -129.44Mkr -124.06M
Operating Cash Flowkr -28.10Mkr -17.00Mkr -37.98Mkr -129.44Mkr -124.06M
Investing Cash Flowkr -109.50Mkr -19.80Mkr -625.20Mkr 0.00kr 0.00
Financing Cash Flowkr -195.50Mkr 571.90Mkr 634.70Mkr -818.00Kkr 486.39M

Currency in SEK

InDex Pharmaceuticals Holding AB Earnings and Revenue History

-800M-400M0400M-240000 %-160000 %-80000 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin

InDex Pharmaceuticals Holding AB Liabilities to Assets

01.5B3B4.5B0 %10 %20 %30 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

InDex Pharmaceuticals Holding AB Cash Flow

-750M-500M-250M0250M500M750M201720182019202020212022202320242025OperatingInvestingFinancing

InDex Pharmaceuticals Holding AB Forecast EPS vs Actual EPS

-8-6-4-20Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26EPS EstimateBeatMiss